A prospective randomized clinical trial (NCT02933970) has compared the efficacy of hepatitis C virus infection treatment via facilitated telemedicine integrated into opioid treatment programmes (n = 290) versus standard-of-care off-site hepatitis specialist referral (n = 312). The study was conducted across opioid treatment programmes in New York, USA. In the telemedicine group, 92.4% of patients initiated treatment compared with 40.4% in the referral group. Intention-to-treat cure percentages were 90.3% in the telemedicine group and 39.4% in the referral group.

中文翻译：

---

阿片类药物治疗计划中丙型肝炎病毒治疗的远程医疗

一项前瞻性随机临床试验 (NCT02933970) 比较了通过整合到阿片类药物治疗计划中的便利远程医疗 ( n = 290) 与标准护理异地肝炎专家转诊 ( n = 312) 治疗丙型肝炎病毒感染的疗效。该研究是在美国纽约的阿片类药物治疗项目中进行的。在远程医疗组中，92.4% 的患者开始接受治疗，而转诊组中这一比例为 40.4%。远程医疗组的意向治疗治愈率为 90.3%，转诊组为 39.4%。